Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: A pilot case-control study

Arthritis Research and Therapy

Volumn 9, Issue 4, 2007, Pages

  Blackman, Marc R ^a   Muniyappa, Ranganath ^a   Wilson, Mildred ^b   Moquin, Barbara E ^a   Baldwin, Howard L ^a   Wong, Kelli A ^a   Snyder, Christopher ^b   Magalnick, Michael ^b   Alli, Shaan ^b   Reynolds, James ^c   Steinberg, Seth M ^d   Goldbach Mansky, Raphaela ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; LIPID; PRASTERONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE MINERAL; CASE CONTROL STUDY; CLIMACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ACTIVITY; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HORMONE RELEASE; HUMAN; PILOT STUDY; PREMENOPAUSE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; BLOOD; BLOOD ANALYSIS; CIRCADIAN RHYTHM; JOINT; PAIN; PATHOLOGY; PHYSIOLOGY;

ADULT; ARTHRITIS, RHEUMATOID; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DEHYDROEPIANDROSTERONE; FEMALE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; JOINTS; PAIN; PILOT PROJECTS; PREMENOPAUSE;

EID: 34548738365     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2271     Document Type: Article

References (42)

1. Roubenoff R Roubenoff RA Cannon JG Kehayias JJ Zhuang H Dawson-Hughes B Dinarello CA Rosenberg IH Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation J Clin Invest 1994, 93:2379-2386 294444 8200971
2. Pincus T Sokka T Wolfe F Premature mortality in patients with rheumatoid arthritis: Evolving concepts Arthritis Rheum 2001, 44:1234-1236 10.1002/ 1529-0131(200106)44:6<1234::AID-ART213>3.0.CO;2-R 11407680
3. Riise T Jacobsen BK Gran JT Haga HJ Arnesen E Total mortality is increased in rheumatoid arthritis. A 17-year prospective study Clin Rheumatol 2001, 20:123-127 10.1007/PL00011191 11346224
4. Rall LC Roubenoff R Rheumatoid cachexia: Metabolic abnormalities, mechanisms and interventions Rheumatology (Oxford) 2004, 43:1219-1223 10.1093/rheumatology/keh321 15292530
5. Corpas E Harman SM Blackman MR Human growth hormone and human aging Endocr Rev 1993, 14:20-39 10.1210/er.14.1.20 8491152
6. De Benedetti F Alonzi T Moretta A Lazzaro D Costa P Poli V Martini A Ciliberto G Fattori E Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation J Clin Invest 1997, 99:643-650 507846 9045866
7. Templ E Koeller M Riedl M Wagner O Graninger W Luger A Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis Br J Rheumatol 1996, 35:350-356 10.1093/rheumatology/35.4.350 8624638
8. Masi AT Aldag JC Jacobs JW Rheumatoid arthritis: Neuroendocrine immune integrated physiopathogenetic perspectives and therapy Rheum Dis Clin North Am 2005, 31:131-160, x 10.1016/j.rdc.2004.09.006 15639060
9. Demir H Kelestimur F Tunc M Kirnap M Ozugul Y Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis Scand J Rheumatol 1999, 28:41-46 10.1080/ 03009749950155779 10092164
10. Veldhuis JD Johnson ML Deconvolution analysis of hormone data Methods Enzymol 1992, 210:539-575 1584051
11. Pincus S Singer BH Randomness and degrees of irregularity Proc Natl Acad Sci USA 1996, 93:2083-2088 39913 11607637 10.1073/pnas.93.5.2083
12. Veldhuis JD Iranmanesh A Johnson ML Lizarralde G Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts J Clin Endocrinol Metab 1990, 71:1616-1623 2172282
13. Denko CW Malemud CJ The serum growth hormone to somatostatin ratio is skewed upward in rheumatoid arthritis patients Front Biosci 2004, 9:1660-1664 10.2741/1354 14977577
14. Denko CW Malemud CJ Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases Semin Arthritis Rheum 2005, 35:24-34 10.1016/j.semarthrit.2005.03.001 16084221
15. Lemmey A Maddison P Breslin A Cassar P Hasso N McCann R Whellams E Holly J Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis J Rheumatol 2001, 28:29-34 11196538
16. Matsumoto T Tsurumoto T Inappropriate serum levels of IGF-I and IGFBP-3 in patients with rheumatoid arthritis Rheumatology (Oxford) 2002, 41:3520353 10.1093/rheumatology/41.3.352 11934980
17. Rovensky J Bakosova J Koska J Ksinantova L Jezova D Vigas M Somatotropic, lactotropic and adrenocortical responses to insulin-induced hypoglycemia in patients with rheumatoid arthritis Ann NY Acad Sci 2002, 966:263-270 12114282
18. Toussirot E Nguyen NU Dumoulin G Aubin F Cedoz JP Wendling D Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis Rheumatology (Oxford) 2005, 44:120-125 10.1093/rheumatology/ keh421 15466894
19. Rall LC Walsmith JM Snydman L Reichlin S Veldhuis JD Kehayias JJ Abad LW Lundgren NT Roubenoff R Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion Arthritis Rheum 2002, 46:2574-2577 10.1002/art.10714 12384914
20. Baxter RC Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am J Physiol Endocrinol Metab 2000, 278:E967-976 10826997
21. Le Roith D Scavo L Butler A What is the role of circulating IGF-I? Trends Endocrinol Metab 2001, 12:48-52 10.1016/S1043-2760(00)00349-0 11167121
22. Schaefer F Baumann G Haffner D Faunt LM Johnson ML Mercado M Ritz E Mehls O Veldhuis JD Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: Regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma J Clin Endocrinol Metab 1996, 81:22-31 10.1210/jc.81.1.22 8550755
23. Anders HJ Rihl M Loch O Schattenkirchner M Prediction of creatinine clearance from serum creatinine in patients with rheumatoid arthritis: comparison of six formulae and one nomogram Clin Rheumatol 2000, 19:26-29 10.1007/s100670050006 10752495
24. Lim WH Lim EM McDonald S Lean body mass-adjusted Cockcroft and Gault formula improves the estimation of glomerular filtration rate in subjects with normal-range serum creatinine Nephrology (Carlton) 2006, 11: 250-256 10.1111/j.1440-1797.2006.00560.x 16756641
25. Rosenfeld RG Hwa V New molecular mechanisms of GH resistance Eur J Endocrinol 2004, 15: S11-15 10.1530/eje.0.151S011 15339238
26. Baxter RC Changes in the IGF-IGFBP axis in critical illness Best Pract Res Clin Endocrinol Metab 2001, 15:421-434 10.1053/beem.2001.0161 11800515
27. Thissen JP Verniers J Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture Endocrinology 1997, 138:1078-1084 10.1210/en.138.3.1078 9048612
28. Frost RA Lang CH Alteration of somatotropic function by proinflammatory cytokines J Anim Sci 2004, 82(E-Suppl):E100-09 15471789
29. Picardi A Gentilucci UV Zardi EM Caccavo D Petitti T Manfrini S Pozzilli P Afeltra A TNF-alpha and growth hormone resistance in patients with chronic liver disease J Interferon Cytokine Res 2003, 23:229-35 10.1089/ 107999003321829944 12804065
30. Benbassat CA Lazarus DD Cichy SB Evans TM Moldawer LL Lowry SF Unterman TG Interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro Horm Metab Res 1999, 31:209-215 10226804
31. Nemet D Eliakim A Zaldivar F Cooper DM Effect of rhIL-6 infusion on GH->IGF-I axis mediators in humans Am J Physiol Regul Integr Comp Physiol 2006, 291:R1663-1668 16840657
32. Harbuz MS Jessop DS Is there a defect in cortisol production in rheumatoid arthritis? Rheumatology (Oxford) 1999, 38:298-302 10.1093/ rheumatology/38.4.298 10378704
33. Cutolo M Sulli A Pizzorni C Craviotto C Straub RH Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis Ann NY Acad Sci 2003, 992:107-117 12794051
34. Crofford LJ Kalogeras KT Mastorakos G Magiakou MA Wells J Kanik KS Gold PW Chrousos GP Wilder RL Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis J Clin Endocrinol Metab 1997, 82:1279-1283 10.1210/ jc.82.4.1279 9100607
35. Straub RH Paimela L Peltomaa R Scholmerich J Leirisalo-Repo M Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis Arthritis Rheum 2002, 46:654-662 10.1002/art.10177 11920401
36. Vogl D Falk W Dorner M Scholmerich J Straub RH Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: Relation to other adrenal hormones J Rheumatol 2003, 30:269-275 12563679
37. Straub RH Weidler C Demmel B Herrmann M Kees F Schmidt M Scholmerich J Schedel J Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus Ann Rheum Dis 2004, 63:961-968 1755103 15249323 10.1136/ ard.2003.014274
38. Cutolo M Foppiani L Prete C Ballarino P Sulli A Villaggio B Seriolo B Giusti M Accardo S Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids J Rheumatol 1999, 26:282-288 9972959
39. Straub RH Harle P Yamana S Matsuda T Takasugi K Kishimoto T Nishimoto N Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study Arthritis Rheum 2006, 54:1778-1785 10.1002/art.21826 16729287
40. Krasner AS Glucocorticoid-induced adrenal insufficiency JAMA 1999, 282:671-676 10.1001/jama.282.7.671 10517721
41. Rittmaster RS Loriaux DL Cutler GB Jr Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women J Clin Endocrinol Metab 1985, 61:462-466 2991319
42. Mastorakos G Chrousos GP Weber JS Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans J Clin Endocrinol Metab 1993, 77:1690-1694 10.1210/jc.77.6.1690 8263159